Dr. Nancy Lin: Are CNS Mets Becoming More Treatable? What’s New with STOP-HER2?
Novel Treatments, Medical Community, Challenges and Barriers, Diagnosis and Treatment, Entities of Cancer, MBC Imaging and Profiling, Difficult to Treat, Clinical Research, Obstacles to Better Outcomes, Patient Reported Outcomes and Out of the Box Treatment Options Our MBClife Novel Treatments, Medical Community, Challenges and Barriers, Diagnosis and Treatment, Entities of Cancer, MBC Imaging and Profiling, Difficult to Treat, Clinical Research, Obstacles to Better Outcomes, Patient Reported Outcomes and Out of the Box Treatment Options Our MBClife

Dr. Nancy Lin: Are CNS Mets Becoming More Treatable? What’s New with STOP-HER2?

Brain metastases are unfortunately an all too common and devastating complication of breast cancer. The blood-brain barrier has long been a key obstacle to developing effective systemic therapies; however, newer agents are showing signs of overcoming this challenge. Dr. Nancy Lin explains.

Read More
ER Progression and Resistance: Causes, Consequences, and Hope
Novel Treatments, Obstacles to Better Outcomes, Medical Community, Entities of Cancer, Difficult to Treat, Clinical Research, Precision Oncology, MBC Imaging and Profiling, Translational Research, Basic Science, Diagnosis and Treatment, Patient Reported Outcomes and Out of the Box Treatment Options Our MBClife Novel Treatments, Obstacles to Better Outcomes, Medical Community, Entities of Cancer, Difficult to Treat, Clinical Research, Precision Oncology, MBC Imaging and Profiling, Translational Research, Basic Science, Diagnosis and Treatment, Patient Reported Outcomes and Out of the Box Treatment Options Our MBClife

ER Progression and Resistance: Causes, Consequences, and Hope

Endocrine therapy is an effective way to treat hormone-sensitive breast cancers, but de novo and acquired resistance to this treatment remains a major challenge. In this episode, the Our MBC Life team hears from two dynamic MSK oncologists Dr. Pedram Razavi and Dr. Komal Jhaveri on treatment strategies and the latest research around the problem of endocrine resistance.

Read More